Investing.com -- AIM ImmunoTech (NYSE:AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...

Down 50% With a 5.9% Dividend Yield, Here's Why This Dirt Cheap Value Stock Is Worth Buying in February Want Decades of Passive Income? 2 Top Dividend Stocks to Buy in 2025 and Hold Forever.

Photo of a laptop with the CDC logo on the screen The CDC has removed HIV, LGBTQ and other health data following Trump's executive orders Experts warn this could have serious consequences Experts ...

ending the vaccine stock out. The vaccine, she says, is enough to take the county through the first quarter of the year and has since been distributed to facilities offering vaccination services. Read ...

Some metrics suggest that a market downturn could be around the corner. Regardless of when the next bear market begins, it's important to start preparing now. The more steps you take right now ...

Investing.com -- AIM ImmunoTech (NYSE:AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

“That can form very new viruses [and] cause epidemics.” Immunization reduces the prevalence and severity of seasonal flu, the CDC says, thereby reducing the “very rare” but possible risk ...

It's been a rough week for Tesla stock (TSLA). Shares of the EV giant were on track for a weekly loss of nearly 9% after a third-party report pointed to a slump in China deliveries. Tesla's sales ...